Search Results - "Li Wan Po, Alain"
-
1
Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C1917
Published in British journal of clinical pharmacology (01-03-2010)“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • CYP2C19 polymorphisms may have clinical consequences in relation to drugs extensively metabolized by the enzyme. •…”
Get full text
Journal Article -
2
Journal of clinical pharmacy and therapeutics—Passing on the baton
Published in Journal of clinical pharmacy and therapeutics (01-01-2022)Get full text
Journal Article -
3
Drug compliance and the Morisky Adherence Scale: An expression of concern and a warning
Published in Journal of clinical pharmacy and therapeutics (01-02-2021)“…What is known and objective Every prescriber knows that patients often do not take their medicines as prescribed. Hippocrates, the wise man of Kos, knew over…”
Get full text
Journal Article -
4
Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial
Published in The Lancet (British edition) (18-12-2004)“…We investigated the efficacy and cost-effectiveness of five antimicrobial regimens for mild to moderate facial acne and whether propionibacterial antibiotic…”
Get full text
Journal Article -
5
Genomic research delivering on promises: From rejuvenation to vaccines and pharmacogenetics
Published in Journal of clinical pharmacy and therapeutics (01-06-2020)“…What is known and Objective There has been astounding progress made in the treatment of disease over recent years. This progress is particularly marked in cell…”
Get full text
Journal Article -
6
Maximizing the value of drug stockpiles for pandemic influenza
Published in Emerging infectious diseases (01-10-2009)Get full text
Journal Article -
7
Omicron variant as nature's solution to the COVID‐19 pandemic
Published in Journal of clinical pharmacy and therapeutics (01-01-2022)“…What is Known and Objective Omicron is a variant of the COVID‐19 virus that is causing considerable concern worldwide, with an increasing number of countries…”
Get full text
Journal Article -
8
Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis
Published in BMJ (08-04-2000)“…AbstractObjectives: To evaluate the comparative efficacy and tolerability of topical calcipotriol in the treatment of mild to moderate chronic plaque…”
Get full text
Journal Article -
9
Self-monitoring of anticoagulation
Published in The Lancet (British edition) (12-05-2012)Get full text
Journal Article -
10
Preventing the aortic complications of Marfan syndrome: a case‐example of translational genomic medicine
Published in British journal of clinical pharmacology (01-07-2011)“…The translational path from pharmacological insight to effective therapy can be a long one. We aim to describe the management of Marfan syndrome as a…”
Get full text
Journal Article -
11
Personalised medicine: who is an Asian?
Published in The Lancet (British edition) (26-05-2007)“…The UK Medicines and Healthcare products Regulatory Agency highlighted the recommendation of a lower starting dose of rosuvastatin of 5 mg for Asians.1 The…”
Get full text
Journal Article -
12
Dose–response of minor analgesics in acute pain
Published in British journal of clinical pharmacology (01-03-2007)Get full text
Journal Article -
13
A mathematical model to improve on phenotyping for molecular genetic research in malignant hyperthermia
Published in Pharmacogenetics and genomics (01-12-2009)“…BACKGROUNDThe in-vitro contracture test is the standard test to diagnose malignant hyperthermia (MH) susceptibility. Maximum sensitivity is important for…”
Get full text
Journal Article -
14
Too much, too little, or none at all: dealing with substandard and fake drugs
Published in The Lancet (British edition) (16-06-2001)“…Paul Newton and co-workers report that just over a third of the samples of tablets labelled "artesunate" bought from shops in Cambodia, Laos, Myanmar,…”
Get full text
Journal Article -
15
What lessons can be learnt from withdrawal of mibefradil from the market?
Published in The Lancet (British edition) (20-06-1998)“…Roche recently withdrew mibefradil, a calcium antagonist, from the market. The drug was removed because of the possibility of severe side effects whe it was…”
Get full text
Journal Article -
16
Pharmacogenetics begins to deliver on its promises
Published in BMJ (Online) (23-09-2015)“…Those promises include safer and smarter use of drugs…”
Get full text
Journal Article -
17
Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa
Published in Journal of antimicrobial chemotherapy (01-09-1999)“…The ability of combinations of azlocillin and tobramycin to prevent or delay resistance development in eight Pseudomonas aeruginosa isolates from cystic…”
Get full text
Journal Article -
18
Non-Parenteral Vaccines: Have Not Lived Up To Their Initial Promise Because Of Side Effects
Published in BMJ (Online) (10-07-2004)Get full text
Journal Article -
19
The Cochrane Skin Group. Preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology
Published in Archives of dermatology (1960) (01-12-1998)“…In 1979, Prof Archie Cochrane challenged the medical profession to produce a critical summary of randomized controlled clinical trials according to specialty,…”
Get more information
Journal Article -
20
Extracting numerical data from published reports of pharmacokinetics investigations: method description and validation
Published in Fundamental & clinical pharmacology (01-08-2003)“…A method has been proposed for extracting numerical data when only graphical results are presented. Reports with both graphical and tabular data were…”
Get full text
Journal Article